Gland Pharma, an Indian contract development and manufacturing organization (CDMO), through its Singapore subsidiary Gland Pharma International, has agreed to acquire Cenexi, a French CDMO, at an enterprise value of €230 million. In this regard, the parties have signed a ‘Put Option Agreement’, which is expected to help Gland Pharma foray into the European CDMO […]
Dr. Reddy’s Laboratories has launched Ertapenem for Injection, 1 g/vial, a generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial, which has approval from the US Food and Drug Administration (FDA) for the treatment of various bacterial infections. The Indian pharma company has extended its partnership with Gland Pharma to launch Ertapenem for […]
